Handelsavisen
prelaunch
Companies Healthcare RIC.TO
RI
RIC.TO Toronto Stock Exchange Medical Equipment, Supplies & Distribution

Richards Group Inc

C$28,28
Open in Charts → Attach watcher ⌖
CAD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
4,52 %
Op margin
8,1 %
ROE
7,5 %
Net margin
3,8 %
Debt / equity
0,48
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Richards Group Inc operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to its clients.

Business. Richards Group Inc (RIC.TO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Richards Group Inc is headquartered in Canada and is listed on the Toronto Stock Exchange. Specific details regarding its operating segments and geographic mix are not available.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY3 analysts
3 buy0 hold0 sell
Avg 12m price target42,00

Analyst recommendations

3 analysts · consensus Buy
Buy3
Hold0
Sell0
12-month price target
42,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
3 analysts · indicative
Ownership
not yet wired
Profitability
7,5 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning RIC.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to RIC.TO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Richards Group Inc (RIC.TO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm generates revenue primarily through the sale of products, including capital equipment and consumables. Richards Group Inc is headquartered in Canada and is listed on the Toronto Stock Exchange. Specific details regarding its operating segments and geographic mix are not available.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    Richards Group Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.48, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.85, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow of CAD 17.28 million in the latest period reflects the company's ability to generate cash after capital expenditures.

    Profitability metrics show a return on equity (ROE) of 7.55% and a return on assets (ROA) of 4.08%, both below the industry median for medical equipment and distribution firms. The gross profit margin of 41.56% (178.78 million / 430.18 million) is in line with industry norms, but the operating margin of 8.15% (35.05 million / 430.18 million) suggests room for improvement in cost control.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic shifts and regulatory changes. No material revenue is attributed to international markets, and the company does not report segment-specific performance metrics.

    Looking ahead, the company is projected to grow revenue by 4.5% in the current fiscal year and 3.2% in the next, based on analyst estimates and historical performance. These growth rates are below the industry median of 6.8% for medical equipment and distribution firms. The company's capital expenditure of CAD 2.95 million in the latest period suggests a modest investment in growth.

    The risk assessment highlights a medium liquidity risk, with net cash being negative after subtracting total debt. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. The company's capital structure remains stable, with no material changes in shares outstanding between basic and diluted shares.

    Recent filings and transcripts do not indicate any material changes in the company's operations or strategy. Analysts have issued three "buy" ratings and no "strong buy" or "hold" ratings, with a mean price target of CAD 42.00, suggesting a neutral to slightly bullish outlook.

    Key takeaways
    • Richards Group Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.48.
    • The company's ROE of 7.55% and ROA of 4.08% are below the industry median for medical equipment and distribution firms.
    • Revenue is concentrated in a single business segment, with no disclosed geographic diversification.
    • Analysts project revenue growth of 4.5% in the current fiscal year and 3.2% in the next, below the industry median of 6.8%.
    • Liquidity risk is assessed as medium, with net cash being negative after subtracting total debt.
    • Dilution risk is low, with no near-term pressure from share issuance or convertible debt.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    C$28,28
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    C$217.1M
    Net cash
    -C$103.7M
    Current ratio
    1.9
    Debt / equity
    0.5
    ROA
    4.1%
    ROE
    7.5%
    Cash conversion
    249.0%
    CapEx / revenue
    -0.7%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    2,89
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-23 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate2,89
    Revenueno estimateno estimate449,3M CAD
    Operating incomeno estimateno estimate52,9M CAD
    Full-year consensus mean (period as reported by source) · consensus in CAD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution3 analysts
    Strong buy0
    Buy3
    Hold0
    Sell0
    Strong sell0
    12-month price targetC$42,00 · Median C$42,00
    Low C$42,00High C$42,00
    Operating income · consensus52,9M CAD
    EPS surprise
    −11,5 %
    reported vs consensus · miss
    Revenue surprise
    −4,3 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowC$42,00
    MeanC$42,00
    MedianC$42,00
    HighC$42,00
    SpotC$28,28
    +48.5 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin8,2 %Above median
    Net Margin3,8 %Above median
    ROE7,5 %Above median
    Capex / Rev-0,7 %Above P75
    D/E0,48Below median
    Cash Conv2,49Best in class

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Richards Group Inc Market data — financials · 2026-05-29
    • Richards Group Inc Market data — analyst estimates · 2026-05-29
    • Richards Group Inc Market data — ESG · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    RIC.TOCanonical
    Toronto Stock Exchange · CAD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage